Journal of Affective Disorders
Volume 126, Issue 1 , Pages 39-45 , October 2010

Electroconvulsive therapy-induced persistent retrograde amnesia: Could it be minimised by ketamine or other pharmacological approaches?

  • Emily M. Gregory-Roberts

      Affiliations

    • Brain and Mind Research Institute, University of Sydney, Australia
    • Corresponding Author InformationCorresponding author. Brain and Mind Research Institute, 100 Mallett St, Camperdown, NSW 2050, Australia. Tel.: +61 2 9351 0781; fax: +61 2 9351 0855.
    • ,
  • Sharon L. Naismith

      Affiliations

    • Brain and Mind Research Institute, University of Sydney, Australia
    • ,
  • Karen M. Cullen

      Affiliations

    • School of Medical Sciences, University of Sydney, Australia
    • ,
  • Ian B. Hickie

      Affiliations

    • Brain and Mind Research Institute, University of Sydney, Australia

Received 15 June 2009 ,Revised 28 November 2009 ,Accepted 28 November 2009.

References 

  1. Abraini JH, David HN, Lemaire M. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N. Y. Acad. Sci. 2005;1053:289–300
  2. American Psychiatric Association. Practice Guideline for Major Depressive Disorder in Adults. Washington, DC: American Psychiatric Association; 1993;
  3. Andrade C. Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: a decade of research. Indian J. Psychiatry. 2008;50:244–252
  4. Andrade C, Singh NM, Thyagarajan S, Nagaraja N, Sanjay Kumar Rao N, Suresh Chandra J. Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature. J. Psychiatr. Res. 2008;42:837–850
  5. Andrade C, Thyagarajan S, Singh NM, Vinod PS, Sanjay Kumar Rao N, Chandra JS. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT. J. Neural. Transm. 2008;115:1063–1070
  6. APA Committee on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association; 2001;
  7. Baddeley AD, Wilson BA, Watts FN. Handbook of Memory Disorders. Chichester: Wiley & Sons; 1995;
  8. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry. 2000;47:351–354
  9. Brewer CL, Davidson JR, Hereward S. Ketamine (“Ketalar”): a safer anaesthetic for ECT. Br. J. Psychiatry. 1972;120:679–680
  10. Brun VH, Ytterbo K, Morris RG, Moser MB, Moser EI. Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation. J. Neurosci. 2001;21:356–362
  11. Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben-Yehuda Y, et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J. Nerv. Ment. Dis. 1991;179:526–533
  12. Chamberlin E, Tsai GE. A glutamatergic model of ECT-induced memory dysfunction. Harv. Rev. Psychiatry. 1998;5:307–317
  13. Chen AC, Shin KH, Duman RS, Sanacora G. ECS-induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J. ECT. 2001;17:27–32
  14. Coffey CE, Figiel GS, Weiner RD, Saunders WB. Caffeine augmentation of ECT. Am. J. Psychiatry. 1990;147:579–585
  15. Coffey CE, Weiner RD, Djang WT, Figiel GS, Soady SA, Patterson LJ, et al. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Arch. Gen. Psychiatry. 1991;48:1013–1021
  16. Cohen MR, Swartz CM. Absence of nimodipine premedication effect on memory after electroconvulsive therapy. Neuropsychobiology. 1990;24:165–168
  17. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure?. Am. J. Psychiatry. 1994;151:957–970
  18. Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend. 2003;69:23–28
  19. Dubovsky SL, Buzan R, Thomas M, Kassner C, Cullum CM. Nicardipine improves the antidepressant action of ECT but does not improve cognition. J. ECT. 2001;17:3–10
  20. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 1997;54:597–606
  21. Dwork AJ, Arango V, Underwood M, Ilievski B, Rosoklija G, Sackeim HA, et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am. J. Psychiatry. 2004;161:576–578
  22. Ezzat DH, Ibraheem MM, Makhawy B. The effect of piracetam on ECT-induced memory disturbances. Br. J. Psychiatry. 1985;147:720–721
  23. Farber NB, Kim SH, Dikranian K, Jiang XP, Heinkel C. Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol. Psychiatry. 2002;7:32–43
  24. Farlow MR. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Geriatrics. 2004;59:22–27
  25. Ferrucci R, Bortolomasi M, Vergari M, Tadini L, Salvoro B, Giacopuzzi M, et al. Transcranial direct current stimulation in severe, drug-resistant major depression. J. Affect. Disord. 2009;118:215–219
  26. Goforth HW, Holsinger T. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. J. ECT. 2007;23:23–25
  27. Hickie I, Parsonage B, Parker G. Prediction of response to electroconvulsive therapy: preliminary validation of a sign-based typology of depression. Br. J. Psychiatry. 1990;157:65–71
  28. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol. Psychiatry. 1995;37:151–160
  29. Hickie I, Mason C, Parker G. Comparative validity of two measures of psychomotor function in patients with severe depression. J. Affect. Disord. 1996;37:143–149
  30. Hickie IB, Naismith SL, Ward PB, Little CL, Pearson M, Scott EM, et al. Psychomotor slowing in older patients with major depression: relationships with blood flow in the caudate nucleus and white matter lesions. Psychiatry Res. 2007;155:211–220
  31. Himmelseher S, Pfenninger E. The clinical use of S-(+)-ketamine—a determination of its place. Anasthesio. Intensivmed. Notfmed. Schmerzther. 1998;33:764–770
  32. Horne RL, Pettinati HM, Menken M, Sugerman AA, Varga E, Wilson GF. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia. Biol. Psychiatry. 1984;19:13–27
  33. Kamath S, Andrade C, Faruqi S, Venkataraman BV, Naga Rani MA, Candade VS. Evaluation of pre-ECS antihypertensive drug administration in the attenuation of ECS-induced retrograde amnesia. Convuls. Ther. 1997;13:185–195
  34. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109:143–148
  35. Koffler SP, Hampstead BM, Irani F, Tinker J, Kiefer RT, Rohr P, et al. The neurocognitive effects of 5day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch. Clin. Neuropsychol. 2007;22:719–729
  36. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth. Analg. 1998;87:1186–1193
  37. Krystal AD, Weiner RD, Dean MD, Lindahl VH, Tramontozzi LA, Falcone G, et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J. Neuropsychiatr. Clin. Neurosci. 2003;15:27–34
  38. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport. 1995;6:869–872
  39. Lamont SR, Stanwell BJ, Hill R, Reid IC, Stewart CA. Ketamine pre-treatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus. Brain Res. 2005;1053:27–32
  40. Levine J, Pomerantz T, Stier S, Belmaker RH. Lack of effect of 6g inositol treatment of post-ECT cognitive function in humans. J. Psychiatr. Res. 1995;29:487–489
  41. Lisanby SH. Electroconvulsive therapy for depression. N. Engl. J. Med. 2007;357:1939–1945
  42. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch. Gen. Psychiatry. 2000;57:581–590
  43. Lunn RJ, Savageau MM, Beatty WW, Gerst JW, Staton RD, Brumback RA. Anesthetics and electroconvulsive therapy seizure duration: implications for therapy from a rat model. Biol. Psychiatry. 1981;16:1163–1175
  44. MacPherson R, Loo C. Cognitive impairment following electroconvulsive therapy—does the choice of anesthetic agent make a difference?. J. ECT. 2008;24:52–56
  45. Mattes JA, Pettinati HM, Stephens S, Robin SE, Willis KW. A placebo-controlled evaluation of vasopressin for ECT-induced memory impairment. Biol. Psychiatry. 1990;27:289–303
  46. McCall WV. Levels of evidence, causality, and clinical significance. J. ECT. 2007;23:69–70
  47. McCall WV, Dunn A, Rosenquist PB, Hughes D. Markedly suprathreshold right unilateral ECT versus minimally suprathreshold bilateral ECT: antidepressant and memory effects. J. ECT. 2002;18:126–129
  48. McCall WV, Dunn A, Rosenquist PB. Quality of life and function after electroconvulsive therapy. Br. J. Psychiatry. 2004;185:405–409
  49. McCall WV, Prudic J, Olfson M, Sackeim H. Health-related quality of life following ECT in a large community sample. J. Affect. Disord. 2006;90:269–274
  50. McDaniel WW, Sahota AK, Vyas BV, Laguerta N, Hategan L, Oswald J. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J. ECT. 2006;22:103–106
  51. McElhiney MC, Moody BJ, Steif BL, Prudic J, Devanand DP, Nobler MS, et al. Autobiographical memory and mood: effects of electroconvulsive therapy. Neuropsychology. 1995;9:501–517
  52. McInnes EJ, James NM. A comparison of ketamine and methohexital in electroconvulsive therapy. Med. J. Aust. 1972;1:1031–1032
  53. Mitchell P, Torda T, Hickie I, Burke C. Propofol as an anaesthetic agent for ECT: effect on outcome and length of course. Aust. NZ J. Psychiatry. 1991;25:255–261
  54. Morgan CJ, Curran HV. Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl.). 2006;188:408–424
  55. Morgan CJA, Monaghan L, Curran HV. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction. 2004;99:1450–1461
  56. Nagaraja N, Andrade C, Sudha S, Singh NM, Chandra JS, Venkataraman BV. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology (Berl.). 2007;190:73–80
  57. Naismith SL, Longley WA, Scott EM, Hickie IB. Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry. 2007;7:32
  58. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 2003;23:10841–10851
  59. Ng C, Schweitzer I, Alexopoulos P, Celi E, Wong L, Tuckwell V, et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J. ECT. 2000;16:370–379
  60. Nobler MS, Sackeim HA. Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. J. ECT. 2008;24:40–45
  61. Ostroff R, Gonzales M, Sanacora G. Antidepressant effect of ketamine during ECT. Am. J. Psychiatry. 2005;162:1385–1386
  62. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J. ECT. 2004;20:13–20
  63. Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann. N. Y. Acad. Sci. 2003;1003:250–272
  64. Pedler M. Shock Treatment: A Survey of People's Experiences of Electro-Convulsive Therapy (ECT). London: MIND; 2001;
  65. Petrie RX, Reid IC, Stewart CA. The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review. Pharmacol. Ther. 2000;87:11–25
  66. Pfenninger EG, Durieux ME, Himmelseher S. Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers. Anesthesiology. 2002;96:357–366
  67. Pigot M, Andrade C, Loo C. Pharmacological attenuation of electroconvulsive therapy-induced cognitive deficits: theoretical background and clinical findings. J. ECT. 2008;24:57–67
  68. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33:88–109
  69. Porter R, Heenan H, Reeves J. Early effects of electroconvulsive therapy on cognitive function. J. ECT. 2008;24:35–39
  70. Prakash J, Kotwal A, Prabhu H. Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial. J. ECT. 2006;22:163–168
  71. Prudic J, Sackeim HA. Electroconvulsive therapy and suicide risk. J. Clin. Psychiatry. 1999;60(Suppl 2):104–110
  72. Prudic J, Fitzsimons L, Nobler MS, Sackeim HA. Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsychopharmacology. 1999;21:285–293
  73. Rao SK, Andrade C, Reddy K, Madappa KN, Thyagarajan S, Chandra S. Memory protective effect of indomethacin against electroconvulsive shock-induced retrograde amnesia in rats. Biol. Psychiatry. 2002;51:770–773
  74. Rasmussen KG, Jarvis MR, Zorumski CF. Ketamine anesthesia in electroconvulsive therapy. Convuls. Ther. 1996;12:217–223
  75. Reid IC, Stewart CA. Seizures, memory and synaptic plasticity. Seizure. 1997;6:351–359
  76. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ. 2003;326:1363
  77. Sachs GS, Gelenberg AJ, Bellinghausen B, Wojcik J, Falk WE, Farhadi AM, et al. Ergoloid mesylates and ECT. J. Clin. Psychiatry. 1989;50:87–90
  78. Sackeim HA. Memory and ECT: from polarization to reconciliation. J. ECT. 2000;16:87–96
  79. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N. Engl. J. Med. 1993;328:839–846
  80. Sackeim HA, Luber B, Moeller JR, Prudic J, Devanand DP, Nobler MS. Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. J. ECT. 2000;16:110–120
  81. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch. Gen. Psychiatry. 2000;57:425–434
  82. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244–254
  83. In:  Scott AIF editors. The ECT Handbook: The Third Report of the Royal College of Psychiatrists' Special Committee on ECT (Council Report CR128). London: Royal College of Psychiatrists; 2005;
  84. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. Predictors of retrograde amnesia following ECT. Am. J. Psychiatry. 1995;152:995–1001
  85. Squire LR, Slater PC, Miller PL. Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up. Arch. Gen. Psychiatry. 1981;38:89–95
  86. Stern RA, Nevels CT, Shelhorse ME, Prohaska ML, Mason GA, Prange AJ. Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings. Biol. Psychiatry. 1991;30:623–627
  87. Stewart C, Reid I. Electroconvulsive stimulation and synaptic plasticity in the rat. Brain Res. 1993;620:139–141
  88. Stewart CA, Reid IC. Ketamine prevents ECS-induced synaptic enhancement in rat hippocampus. Neurosci. Lett. 1994;178:11–14
  89. Stewart C, Jeffery K, Reid I. LTP-like synaptic efficacy changes following electroconvulsive stimulation. NeuroReport. 1994;5:1041–1044
  90. Sudha S, Andrade C, Anand A, Guido S, Venkataraman BV. Nitroprusside and ECS-induced retrograde amnesia. J. ECT. 2001;17:41–44
  91. Tang WK, Ungvari GS, Leung HC. Effect of piracetam on ECT-induced cognitive disturbances: a randomized, placebo-controlled, double-blind study. J. ECT. 2002;18:130–137
  92. In:  Thomas J editors. Australian Prescription Products Guide. Hawthorn, Vic: Australian Pharmaceutical Pub. Co.; 1996;
  93. Tremont G, Stern RA. Use of thyroid hormone to diminish the cognitive side effects of psychiatric treatment. Psychopharmacol. Bull. 1997;33:273–280
  94. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808
  95. Vamos M. The cognitive side effects of modern ECT: patient experience or objective measurement?. J. ECT. 2008;24:18–24
  96. Weiner RD, Rogers HJ, Davidson JR, Squire LR. Effects of stimulus parameters on cognitive side effects. Ann. N. Y. Acad. Sci. 1986;462:315–325
  97. Yamakura T, Harris RA. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology. 2000;93:1095–1101
  98. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry. 2006;63:856–864
  99. Zervas IM, Pehlivanidis AA, Papakostas YG, Markianos M, Papadimitriou GN, Stefanis CN. Effects of TRH administration on orientation time and recall after ECT. J. ECT. 1998;14:236–240
  100. Zupan G, Vitezic D, Mrsic J, Matesic D, Simonic A. Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat. Eur. J. Pharmacol. 1996;310:103–106

PII: S0165-0327(09)00525-4

doi: 10.1016/j.jad.2009.11.018

Journal of Affective Disorders
Volume 126, Issue 1 , Pages 39-45 , October 2010

Article Tools